Literature DB >> 1876635

Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change.

J Bancroft1, A Cook, D Davidson, J Bennie, G Goodwin.   

Abstract

The neuroendocrine response to L-tryptophan infusion was measured at two stages of the menstrual cycle, premenstrually and postmenstrually, in 13 women with and 13 women without premenstrual depression (the MC and NMC groups respectively). Previous studies have shown that in non-depressed women, this challenge test results in an increase in circulating prolactin and growth hormone. In depressed women both responses are blunted. In this study the growth hormone and cortisol responses were smaller in the MC group than the NMC group on both occasions. The prolactin response was blunted premenstrually compared with postmenstrually in both groups. These findings suggest that women who experience premenstrual depression may have neuroendocrine abnormalities throughout the cycle. The neurotransmitter abnormalities reflected in these altered endocrine responses appear to interact with neuroendocrine changes that normally occur premenstrually resulting in a vulnerability to depression at that phase of the cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876635     DOI: 10.1017/s0033291700020407

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  19 in total

Review 1.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

2.  Fluoxetine treatment of severe premenstrual syndrome.

Authors:  D B Menkes; E Taghavi; P A Mason; G F Spears; R C Howard
Journal:  BMJ       Date:  1992-08-08

Review 3.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 4.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.

Authors:  Y Inoue; T Terao; N Iwata; K Okamoto; H Kojima; T Okamoto; R Yoshimura; J Nakamura
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 6.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Menstrual mood disorders are associated with blunted sympathetic reactivity to stress.

Authors:  Rebecca R Klatzkin; Adomas Bunevicius; Catherine A Forneris; Susan Girdler
Journal:  J Psychosom Res       Date:  2013-11-12       Impact factor: 3.006

Review 8.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

Review 9.  A reproductive subtype of depression: conceptualizing models and moving toward etiology.

Authors:  Jennifer L Payne; Jennifer Teitelbaum Palmer; Hadine Joffe
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.